International health insurance demand and future evolution

Everyone prefers being healthy than sick. Individual Health insurance demand derives from the financial risk emanating from illness and the consequent cost of the care needed to return healthy. One thing makes health care different from most other goods and services: it is also an investment; money spent on being healthy today will also have benefits in the future (impact on mortality rates).

Highlights:

  • The economics of health is different, and complicated by adverse selection and moral hazard issues.
  • At the global level, total health expenditure (HE) is growing faster than GDP, and increasing more rapidly in low and middle income countries (close to 6% annual growth on average) than in high-income countries (4%).
  • In Europe the stability in the HE growth rate reflects a rising coverage gap, only partially offset by private insurance (now €140 billions); high heterogeneity among countries reflects differences in public vs. private coverage.
  • There is a statistically stable long-term link between national income and private health insurance. The average income elasticity of private health insurance is significantly higher than one. So, on average and net of other factors, the importance of private health insurance is bound to grow along with economic development.
  • Empirical evidence for Italy shows that Voluntary Health insurance (VHI) is driven by income, households size, sex, age and education. The subscription to term life insurance on the household head is strongly and positively correlated to that of health insurance.

Read the full publication below.

INTERNATIONAL HEALTH
INSURANCE DEMAND
AND FUTURE EVOLUTION

RELATED INSIGHTS

COVID-19 FACTS & FIGURES
Pfizer and BioNTech candidate Covid-19 vaccine showed to be 95% effective in early analysis, an even better result compared to data released last week. Moderna candidate Covid-19 vaccine showed to be 94.5% effective in early trials involving 30,000 people. Switzerland announced ICU beds reached full capacity and no extra units are available. Oxford and AstraZeneca Covid-19 vaccine test results are expected by late December.
EUROPEAN DEFAULTS LIKELY TO STAY LOW
Since March, credit markets have retraced a large part of the Covid-related spread widening, alongside rebounding risk sentiment. Although the rally has been substantial, it has remained defensive with IG outperforming HY on a beta- adjusted basis. The main reason in our view have been concerns about rising defaults.
US: SPLIT GOVERNMENT NOT TOOTHLESS ON GROWTH
Narrow margins in several key swing states sent Democratic candidate Joe Biden to the White House. However, Republicans are more likely than not to keep the majority in the Senate, with voters in Georgia having their final say on two decisive seats on Jan. 5.